The Lancet and the New England Journal of Medicine are among the most influential scientific journals in the world. Both have recently had to retract studies on the effectiveness of COVID-19 treatments after doubts were raised ...
Jun 18, 2020
0
73
Coinciding with World Obesity Day, over 100 medical and scientific organisations have today pledged their support for a consensus statement that recognises unscientific public narratives of obesity as a major cause of weight ...
Mar 3, 2020
2
2
According to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organization's official journal, Genetics in Medicine, there is insufficient evidence to recommend ...
Dec 13, 2019
0
2
Each year, over 2 million people visit U.S. emergency departments for suspected renal colic, which typically causes intense flank or abdominal pain due to kidney stones blocking the urinary track.
Sep 4, 2019
0
8
(HealthDay)—Survey results show that health care professionals have implicit and explicit gender bias, according to a study published online July 5 in JAMA Network Open.
Jul 11, 2019
0
0
UK doctors and surgeons have formulated what is probably the world's first clinical guidance on anal sex before, during, and after diagnosis and treatment for prostate cancer. This consensus guideline, which is aimed at clinicians ...
Jun 10, 2019
0
7
New research published today in the Journal of Eating Disorders finds "clean eating" is perceived as overwhelmingly positive by young people, but those optimistic impressions of "clean diets" may signal a risk for eating ...
Jun 3, 2019
0
1
A review led by a sports scientist at the University of Stirling has set out new international guidelines for protein intake in track and field athletes.
Apr 12, 2019
0
2
(HealthDay)—A consensus statement for the use of hematopoietic stem cell transplantation (HSCT) in the treatment of multiple myeloma (MM) has been developed by Mayo Clinic physicians; the recommendations were published ...
Mar 20, 2019
0
2
A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease (PD). Experts in the ...
Dec 20, 2018
0
0
